HCM
THC icon

Hollencrest Capital Management’s Tenet Healthcare THC Stock Holding History

Hollencrest Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.42K Hold
45
– – ﹤0.01% 839
2026
Q1 		$8.49K Hold
45
– – ﹤0.01% 850
2025
Q4 		$8.94K Sell
45
-100
-69% -$20.2K ﹤0.01% 830
2025
Q3 		$29.4K Hold
145
– – ﹤0.01% 646
2025
Q2 		$25.5K Hold
145
– – ﹤0.01% 642
2025
Q1 		$19.5K Hold
145
– – ﹤0.01% 678
2024
Q4 		$18.3K Buy
145
+100
+222% +$14.9K ﹤0.01% 707
2024
Q3 		$7.48K Hold
45
– – ﹤0.01% 803
2024
Q2 		$5.99K Hold
45
– – ﹤0.01% 813
2024
Q1 		$4.73K Hold
45
– – ﹤0.01% 819
2023
Q4 		$3.4K Hold
45
– – ﹤0.01% 846
2023
Q3 		$2.96K Hold
45
– – ﹤0.01% 874
2023
Q2 		$3.66K Hold
45
– – ﹤0.01% 895
2023
Q1 		$2.67K Hold
45
– – ﹤0.01% 931
2022
Q4 		$2.2K Buy
+45
New +$2.08K ﹤0.01% 935

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Hollencrest Capital Management's THC Position: Q2 2026 in Review

Hollencrest Capital Management held its Tenet Healthcare (THC) position steady in Q2 2026 at 45 shares worth $8.42K. The position accounts for ﹤0.01% of the portfolio, ranked #839.

Hollencrest Capital Management first reported a position in THC in Q4 2022 and has held it in 15 quarters since. The position peaked at $29.4K in Q3 2025. 677 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Hollencrest Capital Management held 45 shares of Tenet Healthcare worth $8.42K as of Q2 2026.
  • Hollencrest Capital Management left its Tenet Healthcare share count unchanged in Q2 2026.
  • Tenet Healthcare made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #839 holding.
  • Hollencrest Capital Management first reported a position in Tenet Healthcare in Q4 2022 and has held it in 15 quarters since.
  • Hollencrest Capital Management's Tenet Healthcare position peaked at $29.4K in Q3 2025.
  • 677 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.